Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
10.63 Up 0.67(6.73%) 4:00PM EDT
|After Hours : 10.80 Up 0.17 (1.60%) 7:31PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 29,502   2,394   1,072  
Cost of Revenue -   -   -  
Gross Profit 29,502   2,394   1,072  
Operating Expenses
Research Development26,292  24,908  13,624  
Selling General and Administrative9,877  7,199  6,800  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (6,667) (29,713) (19,352)
Income from Continuing Operations
Total Other Income/Expenses Net(15,241)(1,367)1,560  
Earnings Before Interest And Taxes(21,908)(31,080)(17,792)
Interest Expense1,518  2,283  2,309  
Income Before Tax(23,426)(33,363)(20,101)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(23,426)(33,363)(20,101)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (23,426) (33,363) (20,101)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (23,426) (33,363) (20,101)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.